Arno Therapeutics, Inc

CIK 1195116 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arno Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Jan 3, 2018SC 13G/A0001535610-18-000002
Mar 31, 2017EFFECT9999999995-17-000711
Mar 31, 2017EFFECT9999999995-17-000708
Mar 30, 201715-12G0001144204-17-017678
Mar 28, 2017POS AM0001144204-17-017086
Mar 28, 2017S-8 POS0001144204-17-017092
Mar 28, 2017POS AM0001144204-17-017085
Feb 14, 2017SC 13G/A0001193125-17-043481
Feb 14, 2017SC 13G/A0001011438-17-000149
Feb 14, 2017SC 13G/A0001019056-17-000207
Jan 9, 201730001359824-17-000009
Jan 9, 2017SC 13D0001359824-17-000008
Jan 5, 2017SC 13G/A0001535610-17-000002
Jan 3, 2017SC 13D/A0001359824-17-000004
Jan 3, 201740001359824-17-000005
Nov 18, 2016DEF 14A0001144204-16-135381
Nov 14, 201610-Q0001144204-16-134183
Nov 4, 2016PRE 14A0001144204-16-131752
Nov 4, 2016424B30001144204-16-131471
Nov 3, 2016EFFECT9999999995-16-006147
Oct 12, 2016S-10001144204-16-127828
Oct 5, 201640000914190-16-000841
Sep 8, 2016SC 13D0001144204-16-123223
Sep 8, 2016SC 13D0001144204-16-123222
Sep 8, 2016SC 13D0001144204-16-123225